Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients

SUMMARY: Bone mineral density (BMD) sometimes cannot be improved by long-term bisphosphonate (BP) therapy in osteoporosis (OP). This study showed that lumbar as well as hip BMD significantly increased after denosumab treatment in patients not responsive to BPs. Thus, denosumab may be a strong OP tre...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Osteoporos Int
Main Authors: Kamimura, M., Nakamura, Y., Ikegami, S., Uchiyama, S., Kato, H., Taguchi, A.
Formato: Artigo
Idioma:Inglês
Publicado: Springer London 2016
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5269470/
https://ncbi.nlm.nih.gov/pubmed/27650642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-016-3764-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares